This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
etfs: Archive
Is This the Right Time to Bet on Clean Energy ETFs?
by Yashwardhan Jain
Despite policy headwinds, surging AI-driven power demand and falling renewable costs are powering clean energy ETFs higher.
alt-energy etfs
Clean Energy ETF (FRNW) Hits New 52-Week High
by Zacks Equity Research
FRNW surges to a new 52-week high, fueled by rising clean energy demand and powerful long-term growth drivers.
etfs
Don't Go All-In on Tech: Diversify With These ETFs
by Yashwardhan Jain
As bubble fears rise and volatility spikes, investors can turn to ETFs like RSP, GLD and IEMG to diversify and cut concentration risk.
artificial-intelligence emerging-markets etfs gold
AI Supercharger: Why Is NVDA-ORCL-DOE Deal a Bull Signal for Tech ETFs?
by Aparajita Dutta
Nvidia and Oracle's DOE-backed AI supercomputer project fuels optimism for tech ETFs, like TRFK and XLK, poised to ride the next wave of AI growth.
artificial-intelligence etfs tech-stocks
4 Sector ETFs to Play for 2026
by Sanghamitra Saha
Consumers are feeling the pinch. Hence, one can bet on high-growth sectors. ETFs like ITA, XLK, VFH & XRT could lead the 2026 rally.
earnings etfs
Here's Why Solar & Clean Energy ETFs Are Shining Bright
by Sanghamitra Saha
Solar and other clean energy ETFs like TAN, CTEX, CNRG & CTEC are surging as AI demand, rate cuts & policy relief boost the long-term growth outlook.
earnings etfs
Navigating Volatility: How Defense ETFs' Dip Offers Long-Run Opportunity
by Aparajita Dutta
Defense ETFs like XAR and ITA slipped in November, but long-term prospects remain strong amid surging global defense spending.
aerospace etfs
ETFs to Buy as AMD Shares Slip After-Hours Despite Q3 Earnings Beat
by Aparajita Dutta
AMD's Q3 beat & AI supercomputer deals signal strong growth, but Amazon's exit makes investment in diversified ETFs like SOXX and IGPT a smart move.
computers earnings etfs
Pharma ETF (IHE) Hit a 52-Week High
by Sanghamitra Saha
IHE just hit a 52-week high. The ETF is up nearly 30% from its low, powered by $LLY's 9.6% past week surge and bold expansion plans. More upside ahead?
etfs pharmaceuticals
With Strong Holiday Outlook for iPhones, Can Apple ETFs Gain Ahead?
by Sanghamitra Saha
Apple's strong iPhone 17 demand and upbeat holiday outlook could favor Apple-heavy ETFs like FTEC, IYW and VGT. But slowing China sales and rich valuations are a drag.
etfs